These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7273060)

  • 1. General dermatologic use of hydroxamic acid.
    Solano E
    Clin Ther; 1980; 3(4):229-33. PubMed ID: 7273060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufexamac in the treatment of skin diseases in general practice.
    Valle-Jones JC
    Practitioner; 1974 Sep; 213(1275):383-6. PubMed ID: 4609377
    [No Abstract]   [Full Text] [Related]  

  • 3. A non-steroidal anti-inflammatory cream. A report from the General Practitioner Research Group.
    Practitioner; 1975 May; 214(1283):689-692. PubMed ID: 1096128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].
    Aertgeerts P; Albring M; Klaschka F; Nasemann T; Patzelt-Wenczler R; Rauhut K; Weigl B
    Z Hautkr; 1985 Feb; 60(3):270-7. PubMed ID: 3158124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study].
    Katsambas A; Vareltzidis A
    Brux Med; 1973 Aug; 53(8):463-8. PubMed ID: 4751895
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
    Christiansen JV; Gadborg E; Kleiter I; Ludvigsen K; Meier CH; Norholm A; Reiter H; Reymann F; Raaschou-Nielsen W; Sondergaard M; Unna P; Wehnert R
    Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of topical bufexamac in epidermolysis bullosa simplex. A double-blind placebo-controlled crossover trial.
    Fine JD; Johnson L
    Arch Dermatol; 1988 Nov; 124(11):1669-72. PubMed ID: 3178249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contact allergies caused by bufexamac].
    Geier J; Fuchs T
    Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A preliminary study of bufexamac in pediatric dermatology].
    Ricard P; Perras M; Proulx C
    Union Med Can; 1980 Aug; 109(8):1208-11. PubMed ID: 7210329
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inflamed dermatoses. Treatment with Bufexamac. A randomized comparative double-blind study against fluocortinbutyl ester].
    Vakilzadeh F; Macher E
    ZFA (Stuttgart); 1983 Nov; 59(33):1888-91. PubMed ID: 6362257
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contact allergy to bufexamac].
    Frosch PJ; Raulin C
    Hautarzt; 1987 Jun; 38(6):331-4. PubMed ID: 2958428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new non-steroid anti-inflammatory agent in therapy of osteoarthrosis].
    Loizzi P
    Clin Ter; 1980 Mar; 92(5):497-512. PubMed ID: 7004750
    [No Abstract]   [Full Text] [Related]  

  • 13. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial.
    Wolf-Jürgensen P
    Curr Med Res Opin; 1979; 5(10):779-84. PubMed ID: 373992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of diaper rash with Parfenac lipid ointment (bufexamac). A study by Austrian pediatricians].
    Lubec G
    Padiatr Padol; 1989; 24(3):227-36. PubMed ID: 2682472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of halcinonide cream, 0.1 percent, in the treatment of moderate and severe dermatoses.
    Belknap BS; Dobson RL
    Cutis; 1981 Apr; 27(4):433-5. PubMed ID: 7226895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical tests with Nerisona cream (SH K 183 MB)].
    Muhafra J
    Z Hautkr; 1976; 51 Suppl 1():56-9. PubMed ID: 795191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of 2% dexamethasone linoleate cream in various dermatoses].
    Gratacos R
    Med Cutan Ibero Lat Am; 1981; 9(2):149-54. PubMed ID: 7026929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.